Stay on This Page Pinned Yesterday We are updating this story in real time as new information breaks. Stay on this page for ...

Tempus AI, Inc. TEM shares fell in Tuesday's extended trading after the company released its fourth-quarter earnings report, ...

This morning, shares are trading around $56, down more than 5% from the prior close after an after-hours selloff followed Tuesday's report.

Q4 2025 earnings call recap: 33%+ core growth, 69% Insights surge, $1.59B 2026 guide, $65M EBITDA, ASP upside—read now.

Tempus AI (NASDAQ: TEM) appears to be a smart buy for tech traders as it is a leading provider of AI-enabled services and ...

Tempus AI (NASDAQ:TEM) executives highlighted accelerating growth across both its diagnostics and data businesses during the company’s fourth-quarter and full-year 2025 fiscal results conference call, ...

Tempus HRD-RNA is an AI-driven, 1,660-gene logistic regression model designed to identify patients likely to respond to ...

Here's a look at Tempus AI's past performance and the resulting price change: Shares of Tempus AI were trading at $58.37 as ...

Q4 2025 Earnings Call February 24, 2026 4:30 PM ESTCompany ParticipantsElizabeth Krutoholow - Vice President of Investor ...

Tempus AI, Inc. (NASDAQ:TEM) shares are climbing today after the company unveiled a new AI-powered cancer diagnostic ...

Tempus AI TEM rose on Wednesday after the company unveiled its new HRD-RNA algorithm, an AI-driven tool designed to improve ...